<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01333683</url>
  </required_header>
  <id_info>
    <org_study_id>HAS</org_study_id>
    <nct_id>NCT01333683</nct_id>
  </id_info>
  <brief_title>Tinnitus and Arterial Hypertension</brief_title>
  <official_title>Tinnitus and Arterial Hypertension.is There Any Relationship?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Faculdade de Medicina de Valenca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Faculdade de Medicina de Valenca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many authors link tinnitus to arterial hypertension. The aim of this study is to establish a&#xD;
      possible relationship between them, analyze the severity of tinnitus related to arterial&#xD;
      hypertension and analyze a possible influence of ototoxic drugs used to treat arterial&#xD;
      hypertension&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arterial hypertension has been cited as a possible tinnitus etiology. Vascular abnormalities&#xD;
      associated with it may account for cochlear and central nervous system. However, a&#xD;
      relationship between tinnitus and arterial hypertension has never been established. The aim&#xD;
      of this study is to analyze this relationship, comparing groups with and without arterial&#xD;
      hypertension and the incidence of tinnitus amongst them. Inclusion and exclusion criteria try&#xD;
      to isolate arterial hypertension as the main etiological factor, as much as possible.&#xD;
      Presbycusis, noise exposure, metabolical diseases and genetic factors will be ruled out. A&#xD;
      comparison will be performed inside the arterial hypertension group between subgroups that&#xD;
      use or not ototoxic medications, such as furosemide and beta-blockers&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of tinnitus - have tinnitus x don't have tinnitus</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>The purpose of this study is to compare tinnitus incidence between patients with and without arterial hypertension.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of tinnitus - Tinnitus Handicap Inventory</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Severity of tinnitus measured by Tinnitus Handicap Inventory, to evaluate differences between patients with and without arterial hypertension</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tinnitus</condition>
  <condition>Hearing Loss</condition>
  <condition>Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Normal subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AH</arm_group_label>
    <description>Arterial hypertension patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients agedd between 40 and 50&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 40 and 50&#xD;
&#xD;
          -  arterial hypertension for group 1&#xD;
&#xD;
          -  at least 5 years standing arterial hypertension&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic noise exposure&#xD;
&#xD;
          -  metabolic diseases&#xD;
&#xD;
          -  family antecedents of hearing loss (except for presbycusis)&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  use of ototoxic drugs (except for anti-hypertensives)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo R Figueiredo, MD,MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Otosul, Valença Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculdade de Medicina de Valença</name>
      <address>
        <city>Valença</city>
        <state>RJ</state>
        <zip>27660-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2011</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculdade de Medicina de Valenca</investigator_affiliation>
    <investigator_full_name>Ricardo Rodrigues Figueiredo</investigator_full_name>
    <investigator_title>M.D, MSc</investigator_title>
  </responsible_party>
  <keyword>tinnitus</keyword>
  <keyword>hearing loss</keyword>
  <keyword>arterial hypertension</keyword>
  <keyword>ototoxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Tinnitus</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

